Characteristic N=340
Treatment indication, n (%) Risk of functional impairment Discomfort due to ulceration Cosmetic disfigurement 61 (18.3%) 47 (13.9%) 229 (67.8%)
Age of propranolol initiation months 1-2 months 3-6 months 6-12 months >12 months 10 (2.9%) 79 (23.2%) 151 (44.4%) 66 (19.4%) 34 (10%)
Propranolol dosage 1 mg/kg/d 2 mg/kg/d 2.5 mg/kg/d 4 mg/kg/d 3 (0.9%) 332 (97.6%) 4 (1.2%) 1 (0.3%)
Total length of propranolol treatment, mean (range) [SD] <3 weeks 3-6 weeks 6-12 weeks 3-6 months >6 months 10.71 (0.5 to 44) [6.41] 2 (0.6%) 4 (1.2%) 13 (3.8%) 87 (25.6%) 234 (68.8%)
Propranolol Response None Partial Nearly Complete Complete Missing 10 (2.9%) 59 (17.5%) 174 (51.5%) 95 (28.1%) 2 (4.0%)
Second cycle of propranolol after initial cycle was stopped 14 (4.3%)
Propranolol Adverse Events Hypoglycemia Bronchospasm Irritability/agitation Vomiting Diarrhea Fatigue 21 (6.2%) 2 (9.5%) 2 (9.5%) 8 (38.1%) 1 (4.8%) 2 (9.5%) 6 (28.6%)
Laser Therapy, n (%) 24 (7.3%)
Surgical Excision, n (%) 32 (9.8%)
Corticosteroid Treatment, n (%) 12 (3.7%)